Dr. Verjee, CEO of Versante International, LLC, will speak at GTC BIO’s upcoming Challenges in Global Clinical Trials conference.  The conference will take place in San Diego, CA, on January 28 and 29, http://www.gtcbio.com/conferenceDetails.aspx?id=170.  The title of Dr. Verjee’s presentation is Leveraging Biometrics and Niche Global Expertise to Mitigate Risk and Increase the Efficiency of Clinical Development